Results 211 to 220 of about 47,840 (254)

[ESBL – risk factors and treatment].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2016
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Molecular characterization of plasmid-encoded blaTEM, blaSHV and blaCTX-M among extended spectrum β-lactamases [ESBLs] producing Acinetobacter baumannii

British Journal of Biomedical Science, 2018
Acinetobacter baumannii associated with nosocomial infections are among the top six drug resistant microbes. Extensive use of the β-lactam group of antibiotics has resulted in the emergence of drug resistance and has raised a major clinical crisis. Among
A. Smiline, J. Vijayashree, A. Paramasivam   +2 more
semanticscholar   +1 more source

Colonization with Enterobacteriaceae-Producing ESBLs, AmpCs, and OXA-48 in Wild Avian Species, Spain 2015–2016

Microbial Drug Resistance, 2018
Antibiotic resistance is a global threat of complex and changeable epidemiology. The role of wild birds in the dissemination of antibacterial resistance might be underestimated.
J. Oteo, Aida Mencía, Verónica Bautista, Natalia Pastor, Noelia Lara, Fernando González-González, F. J. García-Peña, José Campos   +7 more
semanticscholar   +1 more source

Effects of low-intensity and low-frequency ultrasound combined with tobramycin on biofilms of extended-spectrum beta-lactamases (ESBLs) Escherichia coli.

FEMS Microbiology Letters, 2019
Low-intensity and low-frequency ultrasound (LILFU) can enhance the bactericidal action of antibiotics against various sensitive bacterial species. The current study investigated the effects of LILFU combined with tobramycin on extended-spectrum beta ...
Yuru Hou, Min Yang, Hexun Jiang, Dairong Li, Yonghong Du   +4 more
semanticscholar   +1 more source